BRIEF published on 06/30/2026 at 02:05, 2 hours 32 minutes ago Analyse financière de MedMira pour le troisième trimestre de l'exercice 2026 et efforts d'expansion sur le marché Résultats Trimestriels Approbation Réglementaire Expansion Du Marché Test De Dépistage De La Syphilis Données Financières De MedMira
BRIEF published on 06/30/2026 at 02:05, 2 hours 32 minutes ago MedMira's Q3 FY2026 Financial Review and Market Expansion Efforts Regulatory Approval Market Expansion Quarterly Results Syphilis Test MedMira Financials
PRESS RELEASE published on 06/30/2026 at 02:00, 2 hours 37 minutes ago MedMira Reports Third Quarter Results FY2026 MedMira Inc. (TSXV:MIR) reports on Q3 FY2026 financial results, advances regulatory process for Multiplo® Complete Syphilis Antibody Test, and increases international market interest Financial Results Regulatory Approval MedMira Inc. International Markets Rapid Diagnostic Tests
BRIEF published on 04/02/2026 at 04:05, 2 months 28 days ago MedMira Inc. Q2 FY2026 Financial Results Overview Net Loss Operating Expenses MedMira Financial Results McKesson Partnership Q2 FY2026 Revenue
BRIEF published on 04/02/2026 at 04:05, 2 months 28 days ago Aperçu des résultats financiers de MedMira Inc. pour le deuxième trimestre de l'exercice 2026 Perte Nette Résultats Financiers De MedMira Frais D'exploitation Partenariat McKesson Chiffre D'affaires Du Deuxième Trimestre De L'exercice 2026
PRESS RELEASE published on 04/02/2026 at 04:00, 2 months 28 days ago MedMira Reports Second Quarter Results FY2025 MedMira Inc. reports partnership with McKesson, financial results and progress on new tests. The company aims to expand market reach and improve sales Financial Results Clinical Trials MedMira Inc. RVF Technology McKesson Partnership
BRIEF published on 12/31/2025 at 02:05, 5 months 30 days ago MedMira Reports First Quarter Results for FY2026 Health Canada MedMira Q1 Financials MiROQ Technology Reveal® TP
BRIEF published on 12/31/2025 at 02:05, 5 months 30 days ago MedMira publie ses résultats du premier trimestre de l'exercice 2026 MedMira Santé Canada Technologie MiROQ Reveal® TP Résultats Financiers Du T1
PRESS RELEASE published on 12/31/2025 at 02:00, 5 months 30 days ago MedMira Reports First Quarter Results FY2026 MedMira Inc. reports Health Canada approval for Reveal® TP (Syphilis) rapid test, progress in clinical trials, and financial results for Q1 FY2026 Financial Results Clinical Trials MedMira Inc. Health Canada Approval Reveal® TP
BRIEF published on 11/29/2025 at 03:05, 7 months 1 day ago MedMira publie ses résultats financiers pour l'exercice 2025 Résultats Financiers MedMira Exercice 2025 Tests Diagnostiques Technologie MiROQ
Published on 06/30/2026 at 02:00, 2 hours 37 minutes ago MedMira Reports Third Quarter Results FY2026
Published on 06/30/2026 at 00:05, 4 hours 32 minutes ago American Critical Minerals Announces Completion of Warrant Exercise Incentive Program
Published on 06/29/2026 at 23:46, 4 hours 51 minutes ago 1933 Industries Reports Third Quarter 2026 Financial Results
Published on 06/29/2026 at 22:01, 6 hours 36 minutes ago AIP Realty Trust Announces Voting Results of Annual General and Special Meeting of Unitholders
Published on 06/29/2026 at 15:00, 13 hours 37 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 22:47, 5 hours 49 minutes ago Correction d’un communiqué du 29.06.2026 22:05 CET/CEST - ABIVAX: Résultats positifs de la partie 2 de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les ...
Published on 06/29/2026 at 22:05, 6 hours 32 minutes ago ABIVAX: Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité
Published on 06/29/2026 at 22:05, 6 hours 32 minutes ago Abivax Reports Positive ABTECT Maintenance Part 2 Results for Obefazimod, Demonstrating Meaningful Clinical Benefit in Refractory UC Patients and Strengthening the Phase 3 Maintenance Safety Database
Published on 06/29/2026 at 20:30, 8 hours 7 minutes ago Shelly Group SE: Annual General Meeting approves dividend of EUR 0.13 per share – shareholders approve all agenda items
Published on 06/29/2026 at 20:00, 8 hours 36 minutes ago IGEL Appoints James Millington as Field CTO for Healthcare in EMEA
Published on 06/29/2026 at 18:30, 10 hours 7 minutes ago Accor and H World Group expand long-term partnership across direct booking and loyalty platforms
Published on 06/29/2026 at 18:30, 10 hours 7 minutes ago Accor et H World Group : extension du partenariat de long terme aux plateformes de réservation directe et de fidélité
Published on 06/29/2026 at 17:45, 10 hours 52 minutes ago Succès de l’émission obligataire de 1,5 milliard d’euros
Published on 06/29/2026 at 17:45, 10 hours 52 minutes ago Déclaration hebdomadaire de rachat d'actions
